date:Nov 28, 2022
set by FX and generated an Adjusted EBITDA of CHF 237 million (US$248.6) million.
Method in the merger
The merging companies indicate that their successful track records of investing in and delivering ground-breaking innovations that create and reshape growth markets will be combined in DSM-Firmenich. The new company will operate at the highest safety and quality standards and maintain regional manufacturing.
DSM-Firmenich will be well-positioned to accelerate growth by addressing shifts in co